2025 annual financial data
Pliant Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -150,073,000 USD and net income was -149,344,000 USD.
Operating cash flow was -128,336,000 USD.
Get free Pliant Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -150,073,000 USD
- Net income
- -149,344,000 USD
- Operating cash flow
- -128,336,000 USD